MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-131

  1. 1,445 Posts.
    lightbulb Created with Sketch. 3151
    Hi @Wilba32,

    not sure if you're attending the AGM. If not, I was minded to put a motion of appreciation for the tealady, from the floor so to speak.

    Yes, regarding the trolls...Here's what the 2003 investigators in their original attempted review of randomised parachute trials had to say in their Conclusions:

    " As with many interventions intended to prevent ill health, the effectiveness of parachutes has not been subjected to rigorous evaluation by using randomised controlled trials. Advocates of evidence based medicine have criticised the adoption of interventions evaluated by using only observational data.

    We think that everyone might benefit if the most radical protagonists of evidence based medicine organised and participated in a double blind, randomised, placebo controlled, crossover trial of the parachute.
    "

    I can only agree with that sentiment, and I must admit to especially liking the 'crossover' suggested trial features.

    Cheers
    and GLTAH
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.19
Change
0.085(7.69%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.10 $1.20 $1.09 $13.21M 11.37M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.19
 

Sellers (Offers)

Price($) Vol. No.
$1.19 75212 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.